BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19542459)

  • 1. Multivalent binding of carbohydrates by the human alpha-defensin, HD5.
    Lehrer RI; Jung G; Ruchala P; Andre S; Gabius HJ; Lu W
    J Immunol; 2009 Jul; 183(1):480-90. PubMed ID: 19542459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrocyclin, an antiretroviral theta-defensin, is a lectin.
    Wang W; Cole AM; Hong T; Waring AJ; Lehrer RI
    J Immunol; 2003 May; 170(9):4708-16. PubMed ID: 12707350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
    Valere K; Lu W; Chang TL
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection.
    Hazrati E; Galen B; Lu W; Wang W; Ouyang Y; Keller MJ; Lehrer RI; Herold BC
    J Immunol; 2006 Dec; 177(12):8658-66. PubMed ID: 17142766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
    Wiens ME; Smith JG
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical determinants of human α-defensin 5 activity against non-enveloped viruses.
    Gounder AP; Wiens ME; Wilson SS; Lu W; Smith JG
    J Biol Chem; 2012 Jul; 287(29):24554-62. PubMed ID: 22637473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
    Wiens ME; Smith JG
    J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface.
    Rajabi M; Ericksen B; Wu X; de Leeuw E; Zhao L; Pazgier M; Lu W
    J Biol Chem; 2012 Jun; 287(26):21615-27. PubMed ID: 22573326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity.
    Ding J; Tasker C; Valere K; Sihvonen T; Descalzi-Montoya DB; Lu W; Chang TL
    PLoS One; 2013; 8(9):e76038. PubMed ID: 24086683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
    Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of alpha- and theta-defensins against primary isolates of HIV-1.
    Wang W; Owen SM; Rudolph DL; Cole AM; Hong T; Waring AJ; Lal RB; Lehrer RI
    J Immunol; 2004 Jul; 173(1):515-20. PubMed ID: 15210812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition.
    Tenge VR; Gounder AP; Wiens ME; Lu W; Smith JG
    PLoS Pathog; 2014 Sep; 10(9):e1004360. PubMed ID: 25188351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.
    Mathew B; Nagaraj R
    Peptides; 2015 Sep; 71():128-40. PubMed ID: 26206286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the Bacterial Membrane Disruption Mechanism of Human α-Defensin 5: A Theoretical Study.
    Jung SW; Lee J; Cho AE
    J Phys Chem B; 2017 Feb; 121(4):741-748. PubMed ID: 28067516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability.
    Rajabi M; de Leeuw E; Pazgier M; Li J; Lubkowski J; Lu W
    J Biol Chem; 2008 Aug; 283(31):21509-18. PubMed ID: 18499668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.
    Rapista A; Ding J; Benito B; Lo YT; Neiditch MB; Lu W; Chang TL
    Retrovirology; 2011 Jun; 8():45. PubMed ID: 21672195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adsorption of human defensin 5 on bacterial membranes: simulation studies.
    Awang T; Pongprayoon P
    J Mol Model; 2018 Sep; 24(10):273. PubMed ID: 30187138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.
    Klotman ME; Rapista A; Teleshova N; Micsenyi A; Jarvis GA; Lu W; Porter E; Chang TL
    J Immunol; 2008 May; 180(9):6176-85. PubMed ID: 18424739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus.
    Böffert R; Businger R; Preiß H; Ehmann D; Truffault V; Simon C; Ruetalo N; Hamprecht K; Müller P; Wehkamp J; Schindler M
    Antiviral Res; 2020 May; 177():104779. PubMed ID: 32209394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
    Zhang L
    Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.